Take a nostalgic drive through some of the most breathtaking routes across the U.S.! 🚗✨ From winding roads to stunning ...

Cycling is one of the best ways to explore the beauty of the world around you. No matter if you’re a casual rider or a ...

The situation is no different in dry areas like Kadur, Tarikere, and Birur. The scenic routes are tainted by plastic waste, alcohol bottles, construction debris, and foul-smelling garbage ...

March, with its pleasant weather and vibrant landscapes, is the perfect time to explore scenic routes from Bengaluru. Whether you’re craving misty mountains, coffee-scented air, or serene ...

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report). The company’s shares closed last Friday at $0.75. Leverage the ...

Train journeys have long been the eco-friendly alternative to carbon-spewing plane flights. But far from being the boring cousin of the travel world, trains are enjoyable in their own right ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) – Research analysts at William Blair issued their FY2024 EPS estimates for shares of Mersana Therapeutics in a report released on ...

Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a Outperform recommendation. As of January 29, 2025, the average one-year ...

Airlines have unveiled more than 600 new routes to, from or within the United States for 2025, according to Cirium Diio, an aviation analytics firm. Here are seven route developments to know as ...

MRSN stock opened at $0.64 on Wednesday. The company has a quick ratio of 2.35, a current ratio of 2.35 and a debt-to-equity ratio of 13.35. Mersana Therapeutics has a twelve month low of $0.49 ...

Scenic 90 has maintained icon status in Pensacola for the past 25 years as the city’s ‘50s-inspired “shiny diner.” Now, founder Gus Silivos has passed the torch to longtime restauranteur ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mersana Therapeutics (MRSN – Research Report) and Natera (NTRA – Research Report) with bullish ...